Respiratory resources
SPIRIVA® Respimat® (tiotropium) is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma who experienced one or more severe asthma exacerbations in the preceding year. SPIRIVA Respimat is indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (COPD)
SPIOLTO® Respimat (tiotropium & olodaterol) is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with COPD.
Quick link
PC-GB-109610 V2
May 2024